167 related articles for article (PubMed ID: 15194999)
41. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
43. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762
[TBL] [Abstract][Full Text] [Related]
45. [Clinical studies on pulmonary metastases from differentiated thyroid carcinoma--characteristics of patients with pulmonary metastases which appear before thyroid operation or afterward].
Ozaki O; Ito K; Manabe Y; Nishikawa Y; Mimura T
Nihon Geka Gakkai Zasshi; 1986 Jan; 87(1):79-83. PubMed ID: 3960026
[TBL] [Abstract][Full Text] [Related]
46. [Differentiated cancer of the thyroid: prognostic aspects].
Veroux P; Fazzi C; Cavallaro A; Veroux M; Cannizzaro MA
Chir Ital; 1997; 49(1-2):37-41. PubMed ID: 12743874
[TBL] [Abstract][Full Text] [Related]
47. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
Sugitani I; Fujimoto Y; Yamamoto N
Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
[TBL] [Abstract][Full Text] [Related]
48. Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years.
McWilliams RR; Giannini C; Hay ID; Atkinson JL; Stafford SL; Buckner JC
Cancer; 2003 Jul; 98(2):356-62. PubMed ID: 12872357
[TBL] [Abstract][Full Text] [Related]
49. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
50. Radioiodide treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors.
Nĕmec J; Zamrazil V; Pohunková D; Röhling S
Nuklearmedizin; 1979 May; 18(2):86-90. PubMed ID: 471778
[TBL] [Abstract][Full Text] [Related]
51. Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.
Besic N; Zgajnar J; Hocevar M; Petric R
Ann Surg Oncol; 2009 Apr; 16(4):920-8. PubMed ID: 19189188
[TBL] [Abstract][Full Text] [Related]
52. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.
Wang LY; Palmer FL; Nixon IJ; Thomas D; Patel SG; Shaha AR; Shah JP; Tuttle RM; Ganly I
Thyroid; 2014 Nov; 24(11):1594-9. PubMed ID: 25162180
[TBL] [Abstract][Full Text] [Related]
53. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
54. Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131I.
Zhu RS; Yu YL; Lu HK; Luo QY; Chen LB
Chin Med J (Engl); 2005 Mar; 118(5):425-8. PubMed ID: 15780216
[No Abstract] [Full Text] [Related]
55. [Management of lymph node metastases in well-differentiated and medullary thyroid cancer: retrospective study on 52 cases].
Antonelli AR; Piazza C; Lombardi D; Casigli F
Ann Ital Chir; 2004; 75(3):305-14. PubMed ID: 15605518
[TBL] [Abstract][Full Text] [Related]
56. [Clinical analysis of young adult thyroid papillary cancer patients with bilateral cervical metastases].
Zhang L; Guo Z; Wang YL; Ji QH
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):467-9. PubMed ID: 17686304
[TBL] [Abstract][Full Text] [Related]
57. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
58. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
[TBL] [Abstract][Full Text] [Related]
59. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors in well-differentiated thyroid carcinoma.
Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
